Skip to main navigation Skip to search Skip to main content

The IRELAnD studyinvestigating the role of early low-dose aspirin in diabetes mellitus: a double-blinded, placebo-controlled, randomized trial

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalAmerican Journal of Obstetrics and Gynecology MFM
DOIs
Publication statusPublished - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Medicine
  • Aspirin
  • Diabetes mellitus
  • Placebo
  • Randomized controlled trial
  • Clinical trial
  • Pregnancy
  • Internal medicine
  • Surgery
  • Alternative medicine
  • Endocrinology
  • Pathology
  • Biology
  • Genetics

Cite this